García A - Search Results

1

Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.

Marín F, Roldán V, Climent VE, Ibáñez A, García A, Marco P, Sogorb F, Lip GY. Marín F, et al. Among authors: garcia a. Heart. 2004 Oct;90(10):1162-6. doi: 10.1136/hrt.2003.024521. Heart. 2004. PMID: 15367514 Free PMC article.

2

Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.

Roldán V, Marín F, Blann AD, García A, Marco P, Sogorb F, Lip GY. Roldán V, et al. Among authors: garcia a. Eur Heart J. 2003 Jul;24(14):1373-80. doi: 10.1016/s0195-668x(03)00239-2. Eur Heart J. 2003. PMID: 12871695

3

Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation.

Climent V, Marín F, Mainar L, Roldán V, García A, Martínez JG, Lip GY. Climent V, et al. Among authors: garcia a. Int J Cardiol. 2009 Feb 20;132(2):227-32. doi: 10.1016/j.ijcard.2007.11.044. Epub 2008 Jan 30. Int J Cardiol. 2009. PMID: 18234374

4

Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?

Marín F, Roldán V, Climent V, Garcia A, Marco P, Lip GY. Marín F, et al. Among authors: garcia a. Stroke. 2003 May;34(5):1181-6. doi: 10.1161/01.STR.0000065431.76788.D9. Epub 2003 Mar 27. Stroke. 2003. PMID: 12663879

5

Do protein Z levels influence the prothrombotic state in atrial fibrillation?

Marco P, Marín F, García A, Roldán V, Lip GY. Marco P, et al. Among authors: garcia a. Thromb Res. 2002 May 15;106(4-5):269-70. doi: 10.1016/s0049-3848(02)00142-1. Thromb Res. 2002. PMID: 12297137 No abstract available.

6

[Annexin V levels in survivors of early myocardial infarction].

Roldán V, Marín F, Pineda J, Marco P, Corral J, Climent V, García A, Martínez JG, Sogorb F. Roldán V, et al. Among authors: garcia a. Rev Esp Cardiol. 2002 Dec;55(12):1230-4. doi: 10.1016/s0300-8932(02)76794-8. Rev Esp Cardiol. 2002. PMID: 12459071 Free article. Spanish.

7

Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?

Roldán V, Marín F, García A, Tello-Montoliu A, Lip GY. Roldán V, et al. Among authors: garcia a. Int J Cardiol. 2006 Jun 16;110(2):265-6. doi: 10.1016/j.ijcard.2005.08.057. Epub 2005 Nov 28. Int J Cardiol. 2006. PMID: 16316692 No abstract available.

8

[Underuse of anticoagulant treatment in patients with atrial fibrillation].

García A, Marín F, Arrarte V, Sogorb F. García A, et al. Med Clin (Barc). 2002 Nov 9;119(16):638. doi: 10.1016/s0025-7753(02)73523-9. Med Clin (Barc). 2002. PMID: 12433345 Spanish. No abstract available.

9

Diurnal variation in the intensity of anticoagulation in atrial fibrillation.

García A, Marín F, Sánchez B, Roldán V, Marco P. García A, et al. Stroke. 2002 Jan;33(1):322-4. Stroke. 2002. PMID: 11779936 No abstract available.

10

Diurnal variation of international normalised ratio in patients under oral anticoagulation.

Marín F, Roldán V, García A, Martínez JG, Sogorb F. Marín F, et al. Among authors: garcia a. Thromb Res. 2002 Dec 15;108(5-6):355. doi: 10.1016/s0049-3848(03)00108-7. Thromb Res. 2002. PMID: 12676198 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,534 results

Search Page

Filters